Efficacy and Safety of Fermented Ginseng Powder on Liver Function
NCT03260543 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2018-02-05
Summary
This study was conducted to investigate the effects of daily supplementation of fermented ginseng powder on improvement of Liver function.
Conditions
- Fatty Liver, Nonalcoholic
Interventions
- DIETARY_SUPPLEMENT
-
fermented ginseng powder
tablets (2 tablets/day, 125 mg \& 500 mg/day) for 12 weeks.
- DIETARY_SUPPLEMENT
-
Placebo
Placebo for 12 weeks.
Sponsors & Collaborators
-
Chonbuk National University Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2016-11-30
- Completion
- 2017-08-31
Countries
- South Korea
Study Locations
More Related Trials
-
6-week Safety and PD Study in Adults With NAFLD
NCT03256526 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis
NCT02019056 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
NCT04505436 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effects of Fecal Microbiota Transplantation on Weight in Obese Patients With Non-alcoholic Fatty Liver Disease
NCT04594954 ·Status: UNKNOWN ·Phase: NA
-
The Evaluation of Glycyrrhizic Acid's Pesticide Effect in Treating Liver Damage (Retrospective Study)
NCT02329314 ·Status: UNKNOWN
-
Evaluation of Efficacy, Safety and Tolerability of Aldafermin in a Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study In Subjects With Nonalcoholic Steatohepatitis and Stage 2/3 Fibrosis (ALPINE 2/3)
NCT03912532 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial of BGT-002 Tablets in Subjects With Nonalcoholic Steatohepatitis
NCT06491576 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Oral Trigonella Foenum-graecum Seed Extract Vs Placebo in Treatment of None Alcoholic Fatty Liver Disease
NCT02303314 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
NCT05842512 ·Status: RECRUITING ·Phase: PHASE2
-
Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD
NCT05686174 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver Cirrhosis
NCT01503749 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 Tablets in Adult Patients With NASH
NCT05462353 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
NCT06152991 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Evaluate the Efficacy and Safety of LivPhcD Capsules in the NAFLD Subjects
NCT05930093 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease
NCT06272630 ·Status: COMPLETED ·Phase: PHASE4
-
Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.
NCT02721264 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease Patients
NCT02491905 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases
NCT02077374 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study
NCT06078722 ·Status: UNKNOWN
-
A Clinical Trial of Longqi Jiangzhi Decoction Against Non-alcoholic Fatty Liver Disease
NCT07320456 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Assess the Antifibrotic Activity of Fuzheng Huayu in Chronic Hepatitis C Patients With Hepatic Fibrosis
NCT00854087 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis
NCT05397379 ·Status: COMPLETED ·Phase: PHASE2
-
F573 for Injection for the Treatment of Liver Injury/Failure
NCT05689645 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)
NCT06569524 ·Status: RECRUITING ·Phase: PHASE2
-
2-Week Study In People With Nonalcoholic Fatty Liver Disease
NCT03513588 ·Status: COMPLETED ·Phase: PHASE1